NERVGEN PHARMA CORP. (NGEN) earnings per share
NERVGEN PHARMA CORP. reports in CAD; the
per-share figures below are in CAD as filed with SEC
EDGAR, not US dollars.
Annual history
Fiscal years 2025
CAD / SHARE 2 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-12-31 | -C$0.61 | 2026-03-31 |
| FY 2025 | 2024-12-31 | -C$0.36 | 2026-03-31 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer.
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
NGEN CIK 0001751912 Source: EDGAR filings · all facts